histoculture drug response assay

You have access
Applicability of the Histoculture Drug Response Assay to Predict Platinum Sensitivity and Prognosis in Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

Anticancer Research December 2021, 41 (12) 6287-6292; DOI: https://doi.org/10.21873/anticanres.15450
You have access
Assessment of the Applicability of Integrative Tumor Response Assays in Advanced Epithelial Ovarian Cancer
JU-HYUN KIM, YONG SIK YOON, JIN CHEON KIM and YONG-MAN KIM

Anticancer Research January 2019, 39 (1) 313-318; DOI: https://doi.org/10.21873/anticanres.13113
You have access
Clinical Significance of the Histoculture Drug Response Assay in Breast Cancer
YOSHIAKI SHINDEN, YUKO KIJIMA, MUNETSUGU HIRATA, HIDEO ARIMA, AKIHIRO NAKAJYO, KIYONORI TANOUE, KOSEI MAEMURA and SHOJI NATSUGOE

Anticancer Research November 2016, 36 (11) 6173-6178;
You have access
Class III Beta-tubulin Expression in Non-small Cell Lung Cancer: A Predictive Factor for Paclitaxel Response
TAKUYA OHASHI, TATSUYA YOSHIMASU, SHOJI OURA, YOZO KOKAWA, MITSUMASA KAWAGO, YOSHIMITSU HIRAI, MIWAKO MIYASAKA, YUKA AOISHI, MEGUMI KIYOI, HARUKA NISHIGUCHI, MARIKO HONDA and YOSHITAKA OKAMURA

Anticancer Research May 2015, 35 (5) 2669-2674;
You have access
Independence of Cytotoxic Drug Sensitivity Profiles and Receptor Subtype of Invasive Ductal Breast Carcinoma Demonstrated by the Histoculture Drug Response Assay (HDRA)
KWANG YONG KIM, BONG WHA CHUNG, IK YANG, MOON BO KIM and ROBERT M. HOFFMAN

Anticancer Research December 2014, 34 (12) 7197-7201;
You have access
Progression-free Survival Is Accurately Predicted in Patients Treated with Chemotherapy for Epithelial Ovarian Cancer by the Histoculture Drug Response Assay in a Prospective Correlative Clinical Trial at a Single Institution
PHILL-SEUNG JUNG, DAE-YEON KIM, MOON-BO KIM, SHIN-WHA LEE, JONG-HYEOK KIM, YONG-MAN KIM, YOUNG-TAK KIM, ROBERT M. HOFFMAN and JOO-HYUN NAM

Anticancer Research March 2013, 33 (3) 1029-1034;

Main menu

User menu

Search

histoculture drug response assay